Sonoma Biotherapeutics has emerged from stealth with $40m from investors including Lyell Immunopharma and is developing regulatory T-cell therapies for autoimmune and degenerative diseases.

State Farm Ventures backed a round that will help HopSkipDrive expand across the US and add safety features to its children's ride-sharing service.

Cornes, 3M Ventures and Repsol Energy Ventures contributed to a round that increased the in-mold structural electronics provider's total funding to more than $59m.

Biocodex returned for a $19.8m round that boosted microbiome drug developer MaaT Pharma's overall funding to more than $33m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Dell-backed cloud security platform developer was valued at nearly $3bn in a late-stage round led by Sequoia Capital Global Equities.

SoftBank Vision Fund doubled its participation in the childcare retailer's series E round to $300m, with a further $100m expected early next year.

The tissue analysis technology developer has now raised more than $37m, having received $23.6m in a first tranche of its series C round that was led by PHC Holdings.

The personalised therapy management platform closed a round led by Cardinal Health with backing from Novartis and Kite Pharma, taking its overall funding to more than $82m.